EGI blocking peptide product blog
Tags: Blocking Peptide; EIG121; EGI; EGI blocking peptide;
The EGI kiaa1324 (Catalog #MBS152463) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s EIG121 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).EIG121 peptide is used for blocking the activity of EIG121 antibody. Researchers should empirically determine the suitability of the EGI kiaa1324 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The EGI kiaa1324 product has the following accession number(s) (GI #38569482) (NCBI Accession #NP_065826). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given blocking peptide. We\'ve tested the EIG121 Peptide with the following immunoassay(s):
Western Blot (WB) (Western blot analysis of EIG121 in MCF7 cell lysate with EIG121 antibody at 1 μg/mL in (A) the absence and (B) the presence of blocking peptide.)
Species: Human
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 18 amino acids near the carboxy terminus of human EIG121. Heart, Lung tissues are correlated with this protein. Adenocarcinoma, Breast Neoplasms, Carcinoma, Hyperplasia, Neoplasms, Experimental, Ovarian Neoplasms are some of the diseases may be linked to EIG121 Peptide.